AGP Picks
View all

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on August 26, 2026

Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
FDA Grants Fast Track Designation to SOTIO’s SOT106 ADC for Soft Tissue Sarcoma Treatment, Accelerating Clinical Development
Mirror AI Launches Out of Stealth to Help Professionals Prepare for High-Stakes Interviews
CoreHealth Technologies Acquires Konnected to Expand Wellness Expertise and Program Delivery Capabilities
American Eco Fuels (OTC: AEFI) Provides Corporate Update on SAF Development, Patent Portfolio Growth and Uplisting Strategy
Paratus Sciences Announces Updates to its Board of Directors
BTT Medical Institute Launches First-in-Human Safety Clinical Trial Evaluating Induced Hyperthermia with the Computerized Brain-Guided Abreu BTT 700 Temperature Management System (TMS) Inspired by the Nobel Prize-recognized Malarial Fever Therapy
Tvardi Therapeutics to Participate in Upcoming Investor Events
Greenland Mines Announces Pricing of $20 Million Public Offering
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
Rezolve Ai to Showcase Its Infrastructure for the Agentic Economy at Nasdaq Investor Day on October 6 
SONORO GOLD COMPLETES ACQUISITION OF 23 MINERAL CONCESSIONS TO FURTHER EXPAND THE CERRO CALICHE GOLD PROJECT
Cerence Announces Repurchase of $10 Million of 1.50% Convertible Senior Notes Due 2028
Micron Announces Leadership Appointments to Accelerate Innovation and Growth 
Rail Vision Delivers Strong Commercial Momentum in First Half of 2026 with Revenue Exceeding $1 Million
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM
Eikon Therapeutics to Participate in Investor Conferences in September 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

STEM News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.